User profiles for David R. Boulware
David R BoulwareProfessor of Medicine, University of Minnesota Verified email at Umn.edu Cited by 20168 |
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
…, DW Denning, A Loyse, DR Boulware - The Lancet infectious …, 2017 - thelancet.com
Background Cryptococcus is the most common cause of meningitis in adults living with HIV
in sub-Saharan Africa. Global burden estimates are crucial to guide prevention strategies …
in sub-Saharan Africa. Global burden estimates are crucial to guide prevention strategies …
A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19
DR Boulware, MF Pullen, AS Bangdiwala… - New England journal …, 2020 - Mass Medical Soc
Background Coronavirus disease 2019 (Covid-19) occurs after exposure to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the …
respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the …
Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19
…, JL Thompson, DR Boulware… - … England Journal of …, 2022 - Mass Medical Soc
Background Early treatment to prevent severe coronavirus disease 2019 (Covid-19) is an
important component of the comprehensive response to the severe acute respiratory …
important component of the comprehensive response to the severe acute respiratory …
Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial
… We also note that Boulware and colleagues provided study information and data as … the
conduct of Boulware and colleagues’ trial. It is disturbing to learn that Boulware and colleagues …
conduct of Boulware and colleagues’ trial. It is disturbing to learn that Boulware and colleagues …
The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis
…, DB Meya, TM Chiller, DR Boulware - The Lancet infectious …, 2022 - thelancet.com
Background Cryptococcal meningitis is the most common cause of meningitis in adults living
with HIV in sub-Saharan Africa. The estimates of national, regional, and global burden of …
with HIV in sub-Saharan Africa. The estimates of national, regional, and global burden of …
Single-dose liposomal amphotericin B treatment for cryptococcal meningitis
Background Cryptococcal meningitis is a leading cause of human immunodeficiency virus (HIV)–related
death in sub-Saharan Africa. Whether a treatment regimen that includes a …
death in sub-Saharan Africa. Whether a treatment regimen that includes a …
Effect of early treatment with ivermectin among patients with Covid-19
…, GH Guyatt, DR Boulware… - … England Journal of …, 2022 - Mass Medical Soc
Background The efficacy of ivermectin in preventing hospitalization or extended observation
in an emergency setting among outpatients with acutely symptomatic coronavirus disease …
in an emergency setting among outpatients with acutely symptomatic coronavirus disease …
Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis
Background Cryptococcal meningitis accounts for 20 to 25% of acquired immunodeficiency
syndrome–related deaths in Africa. Antiretroviral therapy (ART) is essential for survival; …
syndrome–related deaths in Africa. Antiretroviral therapy (ART) is essential for survival; …
[HTML][HTML] Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind …
…, NS Bhat, TA Murray, DR Boulware… - The Lancet Infectious …, 2023 - thelancet.com
Background Post-COVID-19 condition (also known as long COVID) is an emerging chronic
illness potentially affecting millions of people. We aimed to evaluate whether outpatient …
illness potentially affecting millions of people. We aimed to evaluate whether outpatient …
Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy
…, MA Sande, PR Bohjanen, DR Boulware - Clinical infectious …, 2008 - academic.oup.com
Background . Cryptococcal meningitis (CM) is the proximate cause of death in 20%–30% of
persons with acquired immunodeficiency syndrome in Africa. Methods . Two prospective, …
persons with acquired immunodeficiency syndrome in Africa. Methods . Two prospective, …